Hims & Hers, Zealand, and Roche — why these weight loss drug stocks are down today ...Middle East

Quartz - Economy
Hims & Hers, Zealand, and Roche — why these weight loss drug stocks are down today

Several weight-loss drug stocks are sliding today as pharmaceutical companies battle for dominance in the booming GLP-1 market — which is projected to hit $105 billion by 2030, according to Morgan Stanley (MS) analysts.

Read more...

    Read More Details
    Finally We wish PressBee provided you with enough information of ( Hims & Hers, Zealand, and Roche — why these weight loss drug stocks are down today )

    Also on site :